• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis.

作者信息

Wang Bing H, von Lueder Thomas G, Kompa Andrew R, Huang Li, Webb Randy, Jordaan Pierre, Atar Dan, Krum Henry

机构信息

Monash Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, VIC 3004, Australia.

Monash Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, VIC 3004, Australia; Department of Cardiology B, Oslo University Hospital Ullevål, 0407 Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway.

出版信息

Int J Cardiol. 2015;186:104-5. doi: 10.1016/j.ijcard.2015.03.116. Epub 2015 Mar 11.

DOI:10.1016/j.ijcard.2015.03.116
PMID:25828104
Abstract
摘要

相似文献

1
Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis.联合血管紧张素受体阻断和中性肽链内切酶抑制可减弱血管紧张素II介导的肾细胞胶原合成。
Int J Cardiol. 2015;186:104-5. doi: 10.1016/j.ijcard.2015.03.116. Epub 2015 Mar 11.
2
Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials.血管紧张素转化酶抑制剂联合治疗在高血压中的作用：来自高血压和心力衰竭试验的启示。
Eur Heart J. 2015 Aug 7;36(30):1967-73. doi: 10.1093/eurheartj/ehv142. Epub 2015 Apr 21.
3
Angiotensin receptor--neprilysin inhibiton (ARNI)--a novel therapeutic concept for management of hypertension and heart failure.血管紧张素受体-中性肽链内切酶抑制剂（ARNI）——一种用于治疗高血压和心力衰竭的新型治疗理念。
Blood Press. 2012 Dec;21(6):329-30. doi: 10.3109/10582452.2012.741765.
4
[ARNI, new abbreviation for a new class of treatment of heart failure].[ARNI，心力衰竭新型治疗药物类别的新缩写]
Rev Med Suisse. 2017 Mar 1;13(552):496-499.
5
Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition.血管紧张素受体脑啡肽酶抑制剂（ARNis）在射血分数降低的慢性心力衰竭中的治疗选择：超越肾素-血管紧张素-醛固酮系统（RAAS）和交感神经系统抑制作用
Int J Cardiol. 2017 Jan 1;226:132-135. doi: 10.1016/j.ijcard.2016.04.180. Epub 2016 May 7.
6
Renin-angiotensin-aldosterone system inhibitors in heart failure.肾素-血管紧张素-醛固酮系统抑制剂在心力衰竭中的应用。
Clin Pharmacol Ther. 2013 Oct;94(4):459-67. doi: 10.1038/clpt.2013.135. Epub 2013 Jul 12.
7
A Test in Context: Neprilysin: Function, Inhibition, and Biomarker.在背景下的检验：脑啡肽酶：功能、抑制和生物标志物。
J Am Coll Cardiol. 2016 Aug 9;68(6):639-653. doi: 10.1016/j.jacc.2016.04.060.
8
Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides.心力衰竭中的 Neprilysin 抑制：除了调节利钠肽之外的机制和底物。
Eur J Heart Fail. 2017 Jun;19(6):710-717. doi: 10.1002/ejhf.799. Epub 2017 Mar 21.
9
Metabolic actions could confound advantageous effects of combined angiotensin II receptor and neprilysin inhibition.代谢作用可能会混淆血管紧张素II受体和中性肽链内切酶联合抑制的有益效果。
Hypertension. 2011 Feb;57(2):e4-5. doi: 10.1161/HYPERTENSIONAHA.110.165159. Epub 2010 Dec 13.
10
Current role of neprilysin inhibitors in hypertension and heart failure.奈普利酶抑制剂在高血压和心力衰竭中的当前作用。
Pharmacol Ther. 2014 Oct;144(1):41-9. doi: 10.1016/j.pharmthera.2014.05.002. Epub 2014 May 14.

引用本文的文献

1
Efficacy of sacubitril/valsartan on improving clinical symptoms in patients with acute myocardial infarction complicated with heart failure: a retrospective study.沙库巴曲缬沙坦对改善急性心肌梗死合并心力衰竭患者临床症状的疗效：一项回顾性研究
PeerJ. 2025 Feb 11;13:e18873. doi: 10.7717/peerj.18873. eCollection 2025.
2
Sacubitril/Valsartan in Dialysis Patients: Update on Current Perspectives.沙库巴曲缬沙坦在透析患者中的应用：当前观点更新
Cardiovasc Drugs Ther. 2025 Feb;39(1):187-193. doi: 10.1007/s10557-023-07481-w. Epub 2023 Jun 22.
3
Sacubitril-valsartan enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis.
沙库巴曲缬沙坦与依那普利在中国背景下治疗急性失代偿性心力衰竭的成本效益分析。
Front Pharmacol. 2023 Mar 2;14:925375. doi: 10.3389/fphar.2023.925375. eCollection 2023.
4
The Impact of Angiotensin Receptor-Neprilysin Inhibitors on Arrhythmias in Patients with Heart Failure: A Systematic Review and Meta-analysis.血管紧张素受体脑啡肽酶抑制剂对心力衰竭患者心律失常的影响：一项系统评价和荟萃分析。
J Innov Card Rhythm Manag. 2022 Sep 15;13(9):5164-5175. doi: 10.19102/icrm.2022.130905. eCollection 2022 Sep.
5
Study of endothelial function and vascular stiffness in patients affected by dilated cardiomyopathy on treatment with sacubitril/valsartan.沙库巴曲缬沙坦治疗扩张型心肌病患者的内皮功能和血管僵硬度研究
Am J Cardiovasc Dis. 2022 Jun 15;12(3):125-135. eCollection 2022.
6
1 year follow Up results of "ARTIM HF TRIAL" (angiotensin receptor neprilysin inhibitor effect on TEI index & left ventricular mass in heart failure).“ARTIM HF TRIAL”（血管紧张素受体脑啡肽酶抑制剂对心力衰竭 TEI 指数和左心室质量的影响）的 1 年随访结果。
Indian Heart J. 2021 Mar-Apr;73(2):205-210. doi: 10.1016/j.ihj.2021.01.010. Epub 2021 Jan 13.
7
ECG Monitoring of Reactions to Sacubitril-valsartan in Heart Failure with Reduced Ejection Fraction.射血分数降低的心力衰竭患者中沙库巴曲缬沙坦反应的心电图监测
J Cardiovasc Imaging. 2020 Oct;28(4):254-256. doi: 10.4250/jcvi.2020.0099.
8
Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature.心肾综合征：涉及心脏、肾脏和血管系统的多器官功能障碍。
Br J Pharmacol. 2020 Jul;177(13):2906-2922. doi: 10.1111/bph.15065. Epub 2020 May 13.
9
Sacubitril/valsartan in HFrEF - Should the aces up our sleeves be played earlier?沙库巴曲缬沙坦用于射血分数降低的心力衰竭——我们的王牌应该更早打出吗？
Int J Cardiol Heart Vasc. 2019 Nov 22;25:100428. doi: 10.1016/j.ijcha.2019.100428. eCollection 2019 Dec.
10
The nephroprotective effect of sacubitril/valsartan in heart failure: insights from the real-life clinical setting.沙库巴曲缬沙坦在心力衰竭中的肾脏保护作用：来自真实临床环境的见解
Intern Emerg Med. 2019 Nov;14(8):1205-1208. doi: 10.1007/s11739-019-02149-6. Epub 2019 Jul 15.